PDB Short entry for 1G5M
HEADER    APOPTOSIS                               01-NOV-00   1G5M              
TITLE     HUMAN BCL-2, ISOFORM 1                                                
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: PROTEIN (APOPTOSIS REGULATOR BCL-2 WITH PUTATIVE FLEXIBLE  
COMPND   3 LOOP REPLACED WITH A PORTION OF APOPTOSIS REGULATOR BCL-X PROTEIN);  
COMPND   4 CHAIN: A;                                                            
COMPND   5 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   3 ORGANISM_COMMON: HUMAN;                                              
SOURCE   4 ORGANISM_TAXID: 9606;                                                
SOURCE   5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE   6 EXPRESSION_SYSTEM_TAXID: 562                                         
KEYWDS    APOPTOSIS                                                             
EXPDTA    SOLUTION NMR                                                          
AUTHOR    A.M.PETROS,A.MEDEK,D.G.NETTESHEIM,D.H.KIM,H.S.YOON,K.SWIFT,           
AUTHOR   2 E.D.MATAYOSHI,T.OLTERSDORF,S.W.FESIK                                 
REVDAT   3   23-FEB-22 1G5M    1       REMARK                                   
REVDAT   2   24-FEB-09 1G5M    1       VERSN                                    
REVDAT   1   21-MAR-01 1G5M    0                                                
JRNL        AUTH   A.M.PETROS,A.MEDEK,D.G.NETTESHEIM,D.H.KIM,H.S.YOON,K.SWIFT,  
JRNL        AUTH 2 E.D.MATAYOSHI,T.OLTERSDORF,S.W.FESIK                         
JRNL        TITL   SOLUTION STRUCTURE OF THE ANTIAPOPTOTIC PROTEIN BCL-2.       
JRNL        REF    PROC.NATL.ACAD.SCI.USA        V.  98  3012 2001              
JRNL        REFN                   ISSN 0027-8424                               
JRNL        PMID   11248023                                                     
JRNL        DOI    10.1073/PNAS.041619798                                       
REMARK   1                                                                      
REMARK   1 REFERENCE 1                                                          
REMARK   1  AUTH   Y.TSUJIMOTO,C.M.CROCE                                        
REMARK   1  TITL   ANALYSIS OF THE STRUCTURE, TRANSCRIPTS, AND PRODUCTS OF      
REMARK   1  TITL 2 BCL-2, THE GENE INVOLVED IN HUMAN FOLLICULAR LYMPHOMA        
REMARK   1  REF    PROC.NATL.ACAD.SCI.USA        V.  83  5214 1986              
REMARK   1  REFN                   ISSN 0027-8424                               
REMARK   2                                                                      
REMARK   2 RESOLUTION. NOT APPLICABLE.                                          
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : CNX 2000                                             
REMARK   3   AUTHORS     : BRUNGER                                              
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 1G5M COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-NOV-00.                  
REMARK 100 THE DEPOSITION ID IS D_1000012262.                                   
REMARK 210                                                                      
REMARK 210 EXPERIMENTAL DETAILS                                                 
REMARK 210  EXPERIMENT TYPE                : NMR                                
REMARK 210  TEMPERATURE           (KELVIN) : 298                                
REMARK 210  PH                             : 7.8                                
REMARK 210  IONIC STRENGTH                 : 20 MM                              
REMARK 210  PRESSURE                       : AMBIENT                            
REMARK 210  SAMPLE CONTENTS                : 15N-BCL-2(1); 15N,13C-BCL-2(1);    
REMARK 210                                   15N,13C-BCL-2(1)                   
REMARK 210                                                                      
REMARK 210  NMR EXPERIMENTS CONDUCTED      : 3D_15N-SEPARATED_NOESY; 3D_13C     
REMARK 210                                   -SEPARATED_NOESY                   
REMARK 210  SPECTROMETER FIELD STRENGTH    : 800 MHZ; 600 MHZ; 500 MHZ          
REMARK 210  SPECTROMETER MODEL             : AVANCE                             
REMARK 210  SPECTROMETER MANUFACTURER      : BRUKER                             
REMARK 210                                                                      
REMARK 210  STRUCTURE DETERMINATION.                                            
REMARK 210   SOFTWARE USED                 : NULL                               
REMARK 210   METHOD USED                   : SIMULATED ANNEALING                
REMARK 210                                                                      
REMARK 210 CONFORMERS, NUMBER CALCULATED   : NULL                               
REMARK 210 CONFORMERS, NUMBER SUBMITTED    : 1                                  
REMARK 210 CONFORMERS, SELECTION CRITERIA  : NULL                               
REMARK 210                                                                      
REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL                
REMARK 210                                                                      
REMARK 210 REMARK: NULL                                                         
REMARK 215                                                                      
REMARK 215 NMR STUDY                                                            
REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION           
REMARK 215 NMR DATA.  PROTEIN DATA BANK CONVENTIONS REQUIRE THAT                
REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON              
REMARK 215 THESE RECORDS ARE MEANINGLESS.                                       
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 465                                                                      
REMARK 465 MISSING RESIDUES                                                     
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE                       
REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER;                   
REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)                            
REMARK 465     RES C SSSEQI                                                     
REMARK 465     MET A     1                                                      
REMARK 465     ALA A     2                                                      
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    ALA A   4      -78.91     65.43                                   
REMARK 500    ARG A   6      126.26   -179.88                                   
REMARK 500    THR A   7       58.70   -177.52                                   
REMARK 500    ASP A  10       62.91     63.13                                   
REMARK 500    TYR A  28      106.11    -47.21                                   
REMARK 500    TRP A  30      -66.27    -96.38                                   
REMARK 500    ALA A  32      -58.70     75.77                                   
REMARK 500    VAL A  36      107.83    178.95                                   
REMARK 500    PRO A  44       82.04    -59.75                                   
REMARK 500    SER A  49       38.10   -147.25                                   
REMARK 500    TYR A 108      -70.05    -78.95                                   
REMARK 500    PHE A 112      -84.95     68.54                                   
REMARK 500    HIS A 120     -123.10    -67.38                                   
REMARK 500    LEU A 121       98.07    179.06                                   
REMARK 500    THR A 122      164.50    167.37                                   
REMARK 500    THR A 125      -56.22   -128.17                                   
REMARK 500    ASP A 140       76.38   -106.95                                   
REMARK 500    ARG A 183      -73.51    -65.89                                   
REMARK 500    PRO A 204     -158.80    -57.86                                   
REMARK 500    SER A 205       79.10   -118.26                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 1BXL   RELATED DB: PDB                                   
REMARK 900 STRUCTURE OF BCL-XL/BAK PEPTIDE COMPLEX, NMR, MINIMIZED AVERAGE      
REMARK 900 STRUCTURE                                                            
REMARK 900 RELATED ID: 1G5J   RELATED DB: PDB                                   
REMARK 900 COMPLEX OF BCL-XL WITH PEPTIDE FROM BAD                              
REMARK 900 RELATED ID: 1G5O   RELATED DB: PDB                                   
REMARK 900 HUMAN BCL-2, ISOFORM 2                                               
DBREF  1G5M A    1    34  UNP    P10415   BCL2_HUMAN       1     34             
DBREF  1G5M A   35    50  UNP    Q07817   BCLX_HUMAN      29     44             
DBREF  1G5M A   92   207  UNP    P10415   BCL2_HUMAN      92    207             
SEQADV 1G5M ALA A   96  UNP  P10415    THR    96 ISOFORM                        
SEQADV 1G5M GLY A  110  UNP  P10415    ARG   110 ISOFORM                        
SEQRES   1 A  166  MET ALA HIS ALA GLY ARG THR GLY TYR ASP ASN ARG GLU          
SEQRES   2 A  166  ILE VAL MET LYS TYR ILE HIS TYR LYS LEU SER GLN ARG          
SEQRES   3 A  166  GLY TYR GLU TRP ASP ALA GLY ASP ASP VAL GLU GLU ASN          
SEQRES   4 A  166  ARG THR GLU ALA PRO GLU GLY THR GLU SER GLU VAL VAL          
SEQRES   5 A  166  HIS LEU ALA LEU ARG GLN ALA GLY ASP ASP PHE SER ARG          
SEQRES   6 A  166  ARG TYR ARG GLY ASP PHE ALA GLU MET SER SER GLN LEU          
SEQRES   7 A  166  HIS LEU THR PRO PHE THR ALA ARG GLY ARG PHE ALA THR          
SEQRES   8 A  166  VAL VAL GLU GLU LEU PHE ARG ASP GLY VAL ASN TRP GLY          
SEQRES   9 A  166  ARG ILE VAL ALA PHE PHE GLU PHE GLY GLY VAL MET CYS          
SEQRES  10 A  166  VAL GLU SER VAL ASN ARG GLU MET SER PRO LEU VAL ASP          
SEQRES  11 A  166  ASN ILE ALA LEU TRP MET THR GLU TYR LEU ASN ARG HIS          
SEQRES  12 A  166  LEU HIS THR TRP ILE GLN ASP ASN GLY GLY TRP ASP ALA          
SEQRES  13 A  166  PHE VAL GLU LEU TYR GLY PRO SER MET ARG                      
HELIX    1   1 ASP A   10  GLN A   25  1                                  16    
HELIX    2   2 VAL A   92  ARG A  109  1                                  18    
HELIX    3   3 ALA A  113  GLN A  118  5                                   6    
HELIX    4   4 THR A  122  PHE A  138  1                                  17    
HELIX    5   5 ASN A  143  ARG A  164  1                                  22    
HELIX    6   6 MET A  166  HIS A  184  1                                  19    
HELIX    7   7 HIS A  184  GLY A  193  1                                  10    
HELIX    8   8 GLY A  194  GLY A  203  1                                  10    
CRYST1    1.000    1.000    1.000  90.00  90.00  90.00 P 1           1          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      1.000000  0.000000  0.000000        0.00000                         
SCALE2      0.000000  1.000000  0.000000        0.00000                         
SCALE3      0.000000  0.000000  1.000000        0.00000